Exalys Therapeutics is developing a portfolio of novel anti-inflammatory therapeutics with best-in-class properties to target a range of diseases with urgent unmet needs and limited treatment options.
Kyverna Therapeutics
8 followers
Generate Biomedicines
5 followers
Artiva Biotherapeutics
2 followers
Dren Bio
1 follower
Trevi Therapeutics
1 follower
Calico
8 followers
Queen's University
8 followers
Maven
6 followers
School District of Philadelphia
5 followers
DECA
4 followers
FieldGuide
4 followers
Schoters
3 followers